Literature DB >> 26389834

Urinary-derived human chorionic gonadotropin to induce tolerance and promote healing in steroid-refractory GvHD.

S G Holtan1, A Panoskaltsis-Mortari2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26389834     DOI: 10.1038/bmt.2015.220

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  5 in total

1.  Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHD.

Authors:  A H Elmaagacli; M Ditschkowski; N K Steckel; T Gromke; H Ottinger; U Hillen; H A Baba; R Trenschel; D W Beelen; M Koldehoff
Journal:  Bone Marrow Transplant       Date:  2014-03-31       Impact factor: 5.483

2.  Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.

Authors:  Shernan G Holtan; Michael R Verneris; Kirk R Schultz; Laura F Newell; Gabrielle Meyers; Fiona He; Todd E DeFor; Gregory M Vercellotti; Arne Slungaard; Margaret L MacMillan; Sarah A Cooley; Bruce R Blazar; Angela Panoskaltsis-Mortari; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-07       Impact factor: 5.742

3.  Epidermal growth factor contamination and concentrations of intact human chorionic gonadotropin in commercial preparations.

Authors:  Sarah J Yarram; Julian Jenkins; Lawrence A Cole; Nathan L Brown; Jonathan R Sandy; Jason P Mansell
Journal:  Fertil Steril       Date:  2004-07       Impact factor: 7.329

4.  Human chorionic gonadotropin as a central regulator of pregnancy immune tolerance.

Authors:  Anne Schumacher; Kristina Heinze; Jeanette Witte; Eileen Poloski; Nadja Linzke; Katja Woidacki; Ana C Zenclussen
Journal:  J Immunol       Date:  2013-02-08       Impact factor: 5.422

5.  Growth modeling of the maternal cytokine milieu throughout normal pregnancy: macrophage-derived chemokine decreases as inflammation/counterregulation increases.

Authors:  Shernan G Holtan; Yiyi Chen; Rajani Kaimal; Douglas J Creedon; Elizabeth Ann L Enninga; Wendy K Nevala; Svetomir N Markovic
Journal:  J Immunol Res       Date:  2015-03-17       Impact factor: 4.818

  5 in total
  2 in total

1.  Low EGF in myeloablative allotransplantation: association with severe acute GvHD in BMT CTN 0402.

Authors:  S G Holtan; L F Newell; C Cutler; M R Verneris; T E DeFor; J Wu; A Howard; M L MacMillan; J H Antin; B R Blazar; D J Weisdorf; A Panoskaltsis-Mortari
Journal:  Bone Marrow Transplant       Date:  2017-06-05       Impact factor: 5.483

2.  Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor.

Authors:  Shernan G Holtan; Andrea L Hoeschen; Qing Cao; Mukta Arora; Veronika Bachanova; Claudio G Brunstein; Jeffrey S Miller; Armin Rashidi; Arne Slungaard; Celalettin Ustun; Gregory M Vercellotti; Erica D Warlick; Brian C Betts; Najla El Jurdi; Fiona He; Chi Chen; Isha Gandhi; John E Wagner; Bruce R Blazar; Pamala Ann Jacobson; Ashraf Shabaneh; Jinhua Wang; Angela Panoskaltsis-Mortari; Margaret L MacMillan; Daniel J Weisdorf
Journal:  Blood Adv       Date:  2020-04-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.